The Effect of Different Auditory Types on Visual Evoked Potentials (VEP)
To investigate the effect of different sound types on pattern visual evoked potential (VEP) responses among healthy adults
Study Overview
Status
Status
Conditions
Conditions
Study Type
Study Type
Enrollment (Actual)
Enrollment
Contacts and Locations
Study Locations
-
-
(State)
-
Riyadh, (State), Saudi Arabia, 12372
- Kholoud Ahmad Bokhary
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
the retina clinic at the Ophthalmology Department at King Abdulaziz University Hospital
Description
Inclusion Criteria:
- Healthy subjects with no ocular or systemic diseases
- Aged between 20 to 60 years
- Subjects with best corrected visual acuity (BCVA) 0.40 LogMAR or better
- Subjects with normal hearing
Exclusion Criteria:
- Subjects with ocular disorders or any neurodegenerative disorders, hearing impairment
- Patient with best visual acuity less than 0.40 LogMAR
- Patients taking neurotoxic drugs
Study Plan
How is the study designed?
Design Details
- Observational Models: COHORT
- Time Perspectives: CROSS_SECTIONAL
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
VEP responses can be influenced by the auditory conditions during visual pathway assessment in healthy adults, with silence producing higher amplitudes than Quran recitation and music exposure at the 1° stimulation size
Time Frame: From January 2026 to June 2026
|
From January 2026 to June 2026
|
Secondary Outcome Measures
Secondary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
• Stimulation size may influence the sensitivity of VEP in detecting functional differences in the visual pathway, with significant correlation between BCVA and P100 amplitude observed during music exposure at 0.25°.
Time Frame: From January 2026 to June 2026
|
From January 2026 to June 2026
|
Collaborators and Investigators
Sponsor
Sponsor
Study record dates
Study Major Dates
Study Start (Actual)
Study Start
Primary Completion (Actual)
Primary Completion
Study Completion (Actual)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (Actual)
First Posted
Study Record Updates
Last Update Posted (Actual)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
Other Study ID Numbers
- E-25-10435 date: 1 Jan.2026
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.